Cancer immunology and immunotherapy [electronic resource] / Glenn Dranoff, Editor.
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Berlin ; Heidelberg ; New York :
Springer,
©2011.
|
| Series: | Current topics in microbiology and immunology ;
v. 344. |
| Subjects: |
Internet
Full Text (via Springer)Online
| Call Number: |
RC268.3 .C36 2011
|
|---|---|
| RC268.3 .C36 2011 | Available |